Metraipolis › archive › dc_73dc742b4ea2

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader-Willi Syndrome — Europe PMC PMID:34300220

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34300220
DOI
10.3390/jcm10143054
License (as archived)
solo-consultazione
Archived
2026-10-07T22:58:53.422Z
SHA-256 of the archived text
ec1f04da0ffcccb7341019852b036f8f32cdb5abf8f7730e61df1b683a4b8237
Stable URL of this page
https://metraipolis.com/documento/dc_73dc742b4ea2

How to cite

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader-Willi Syndrome — Europe PMC PMID:34300220 — Europe PMC (en), https://europepmc.org/article/MED/34300220 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73dc742b4ea2 (Metraipolis archive dc_73dc742b4ea2, sha256 ec1f04da0ffcccb7341019852b036f8f32cdb5abf8f7730e61df1b683a4b8237)
BibTeX
@misc{dc73dc742b4ea2,
  title = {Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader-Willi Syndrome — Europe PMC PMID:34300220},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34300220},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73dc742b4ea2; sha256 ec1f04da0ffcccb7341019852b036f8f32cdb5abf8f7730e61df1b683a4b8237},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/34300220. Agents can read the archived copy with the MCP tool read_document.